Source: International Congress 2017 – Cystic fibrosis in children and adults: treatment dilemmas
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Pavel Drevinek (Praha, Czech Republic). Treating infection or the whole microbiome: which microbes do not matter?. International Congress 2017 – Cystic fibrosis in children and adults: treatment dilemmas

Member's Comments

No comment yet.

Related content which might interest you: Monitoring asthma: no matter how? Source: Eur Respir J 2016; 48: 614-616 Year: 2016 What can we learn about pulmonary infection from studying the microbiome in CF? Source: International Congress 2016 – What can respiratory medicine learn from cystic fibrosis research? Year: 2016 Is it just an infection? Source: Breathe, 14 (3) e100; 10.1183/20734735.021518 Year: 2018 Bacteria in the pathogenesis of COPD: does the load matter? Source: Annual Congress 2010 - Treatment of bronchial infection: beyond the exacerbations Year: 2010 How to think about the microbiome Source: International Congress 2019 – PG16 Assessment and analysis of the lung microbiome Year: 2019 CO2-exhalation: does the system matter? Source: International Congress 2014 – Technical refinements in home mechanical ventilation: what is useful, what is irritating, and what is gadgetry? Year: 2014 The early-life microbiome: the key to respiratory health? Source: Eur Respir Monogr 2019; 83: 67-87 Year: 2019 Harnessing the microbiome to combat inflammation: a hot topic or a credible future? Source: International Congress 2019 – Mechanisms underlying acute exacerbation of respiratory disease Year: 2019 The consequences of microbiome and pathogen dynamics for chronic lung diseases Source: Annual Congress 2012 - The bacterial microbiota: implications for health and disease - joint session with the World Allergy Organisation Year: 2012 The environment and the gut microbiome - interesting association or a rich field for future therapies? Source: International Congress 2018 – Infectious agents and childhood asthma Year: 2018 What is bacterial colonisation in COPD? Source: Eur Respir Monogr 2015; 69: 161-171 Year: 2015 Predicting bacteraemia or rapid identification of the causative pathogen in community acquired pneumonia: where should the priority lie? Source: Eur Respir J 2016; 48: 619-622 Year: 2016 Is the lung microbiome alive? Lessons from Antarctic soil Source: Eur Respir J, 58 (1) 2100321; 10.1183/13993003.00321-2021 Year: 2021 Lower respiratory tract infections in the European GRACE primary care network: Bacterial causes or do viruses also matter? Source: Annual Congress 2011 - Appropriate use of antibiotics in respiratory infections in Europe (the GRACE project) Year: 2011 Applying ecological theories in lung microbiome research: lessons learned from microbial ecology and evolution? Source: Eur Respir Monogr 2019; 83: 50-66 Year: 2019 Bacterial load and contamination in lung microbiota studies Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018 Macrolides, inflammation and the lung microbiome: cause or effect? Source: International Congress 2018 – State of the art session: Airways disease Year: 2018